These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

785 related items for PubMed ID: 19392907

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy.
    Roy AK, McCarthy C, Kiernan G, McGorrian C, Keenan E, Mahon NG, Sweeney B.
    Addiction; 2012 Jun; 107(6):1132-9. PubMed ID: 22168435
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.
    Peles E, Bodner G, Kreek MJ, Rados V, Adelson M.
    Addiction; 2007 Feb; 102(2):289-300. PubMed ID: 17222284
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of long QTc interval in methadone maintenance patients.
    Fonseca F, Marti-Almor J, Pastor A, Cladellas M, Farré M, de la Torre R, Torrens M.
    Drug Alcohol Depend; 2009 Jan 01; 99(1-3):327-32. PubMed ID: 18774239
    [Abstract] [Full Text] [Related]

  • 7. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S, Gossop M, Lintzeris N, Markides V, Strang J.
    Drug Alcohol Rev; 2011 Jul 01; 30(4):388-96. PubMed ID: 21355918
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.
    Fareed A, Patil D, Scheinberg K, Blackinton Gale R, Vayalapalli S, Casarella J, Drexler K.
    J Addict Dis; 2013 Jul 01; 32(3):244-51. PubMed ID: 24074190
    [Abstract] [Full Text] [Related]

  • 10. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study.
    Clausen T, Anchersen K, Waal H.
    Drug Alcohol Depend; 2008 Apr 01; 94(1-3):151-7. PubMed ID: 18155364
    [Abstract] [Full Text] [Related]

  • 11. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.
    Perrin-Terrin A, Pathak A, Lapeyre-Mestre M.
    Fundam Clin Pharmacol; 2011 Aug 01; 25(4):503-10. PubMed ID: 20825488
    [Abstract] [Full Text] [Related]

  • 12. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.
    Ehret GB, Voide C, Gex-Fabry M, Chabert J, Shah D, Broers B, Piguet V, Musset T, Gaspoz JM, Perrier A, Dayer P, Desmeules JA.
    Arch Intern Med; 2006 Jun 26; 166(12):1280-7. PubMed ID: 16801510
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence.
    Chang KC, Huang CL, Liang HY, Chang SS, Wang YC, Liang WM, Lane HY, Chen CH, Stephen Huang SK.
    J Cardiovasc Electrophysiol; 2012 May 26; 23(5):527-33. PubMed ID: 22136144
    [Abstract] [Full Text] [Related]

  • 15. Psychotropic drugs associated with corrected QT interval prolongation.
    van Noord C, Straus SM, Sturkenboom MC, Hofman A, Aarnoudse AJ, Bagnardi V, Kors JA, Newton-Cheh C, Witteman JC, Stricker BH.
    J Clin Psychopharmacol; 2009 Feb 26; 29(1):9-15. PubMed ID: 19142100
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
    Degenhardt L, Randall D, Hall W, Law M, Butler T, Burns L.
    Drug Alcohol Depend; 2009 Nov 01; 105(1-2):9-15. PubMed ID: 19608355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.